{"id":"https://openalex.org/W2891987403","doi":"https://doi.org/10.2147/dddt.s173485","title":"Chemotherapeutic drug targeting to lungs by way of microspheres after intravenous administration","display_name":"Chemotherapeutic drug targeting to lungs by way of microspheres after intravenous administration","publication_year":2018,"publication_date":"2018-09-01","ids":{"openalex":"https://openalex.org/W2891987403","doi":"https://doi.org/10.2147/dddt.s173485","mag":"2891987403","pmid":"https://pubmed.ncbi.nlm.nih.gov/30271120","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6151103"},"language":"en","primary_location":{"id":"doi:10.2147/dddt.s173485","doi":"https://doi.org/10.2147/dddt.s173485","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s173485","pdf_url":null,"source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.2147/dddt.s173485","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023795266","display_name":"Sibghatullah Sangi","orcid":"https://orcid.org/0000-0003-3908-1613","observed_orcids":["https://orcid.org/0000-0003-3908-1613"]},"institutions":[{"id":"https://openalex.org/I118590987","display_name":"Northern Border University","ror":"https://ror.org/03j9tzj20","country_code":"SA","type":"education","lineage":["https://openalex.org/I118590987"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Sibghatullah Sangi","raw_affiliation_strings":["Department of Clinical Pharmacy, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia, sibghatullah.sangi@nbu.edu.sa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia, sibghatullah.sangi@nbu.edu.sa","institution_ids":["https://openalex.org/I118590987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040297048","display_name":"Nagaraja Sreeharsha","orcid":"https://orcid.org/0000-0002-2058-255X","observed_orcids":["https://orcid.org/0000-0002-2058-255X"]},"institutions":[{"id":"https://openalex.org/I4626487","display_name":"King Faisal University","ror":"https://ror.org/00dn43547","country_code":"SA","type":"education","lineage":["https://openalex.org/I4626487"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Nagaraja SreeHarsha","raw_affiliation_strings":["Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0002-2058-255X","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia","institution_ids":["https://openalex.org/I4626487"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066558616","display_name":"Abdulhakim Bawadekji","orcid":"https://orcid.org/0000-0001-6148-5441","observed_orcids":["https://orcid.org/0000-0001-6148-5441"]},"institutions":[{"id":"https://openalex.org/I118590987","display_name":"Northern Border University","ror":"https://ror.org/03j9tzj20","country_code":"SA","type":"education","lineage":["https://openalex.org/I118590987"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Abdulhakim Bawadekji","raw_affiliation_strings":["Department of Biological Sciences, College of Science, Northern Border University, Arar, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0001-6148-5441","affiliations":[{"raw_affiliation_string":"Department of Biological Sciences, College of Science, Northern Border University, Arar, Saudi Arabia","institution_ids":["https://openalex.org/I118590987"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006009964","display_name":"Mouhanad Al Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49451733","display_name":"Universit\u00e9 d'Angers","ror":"https://ror.org/04yrqp957","country_code":"FR","type":"education","lineage":["https://openalex.org/I49451733"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mouhanad Al Ali","raw_affiliation_strings":["Higher Institute of Health and Bio-products of Angers (ISSBA), Angers-France, Universit\u00e9 d'Angers, Angers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Higher Institute of Health and Bio-products of Angers (ISSBA), Angers-France, Universit\u00e9 d'Angers, Angers, France","institution_ids":["https://openalex.org/I49451733"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5023795266"],"corresponding_institution_ids":["https://openalex.org/I118590987"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.2964,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.38548947,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":98},"biblio":{"volume":"Volume 12","issue":null,"first_page":"3051","last_page":"3060"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.6371999979019165,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.6371999979019165,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.2078000009059906,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.14650000631809235,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.7929999828338623},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.6150000095367432},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9300000071525574},{"id":"https://openalex.org/keywords/gelatin-microspheres","display_name":"gelatin microspheres","score":0.9430000185966492},{"id":"https://openalex.org/keywords/spray-drying","display_name":"spray drying","score":0.925000011920929},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.7059999704360962},{"id":"https://openalex.org/keywords/pulmonary-drug-delivery","display_name":"pulmonary drug delivery","score":0.5870000123977661},{"id":"https://openalex.org/keywords/drug-release-kinetics","display_name":"drug release kinetics","score":0.6880000233650208},{"id":"https://openalex.org/keywords/two-compartment-model","display_name":"two-compartment model","score":0.7889999747276306},{"id":"https://openalex.org/keywords/plasma-concentration-time-curve","display_name":"plasma concentration-time curve","score":0.574999988079071},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.5600000023841858},{"id":"https://openalex.org/keywords/lung-cancer-chemotherapy","display_name":"lung cancer chemotherapy","score":0.6359999775886536},{"id":"https://openalex.org/keywords/drug-polymer-ratio","display_name":"drug-polymer ratio","score":0.6110000014305115},{"id":"https://openalex.org/keywords/particle-size-distribution","display_name":"particle size distribution","score":0.6190000176429749},{"id":"https://openalex.org/keywords/in-vivo-biodistribution","display_name":"in vivo biodistribution","score":0.4580000042915344}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6731536984443665},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.6387919187545776},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.635906994342804},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6185263991355896},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5442228317260742},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.5010068416595459},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.49297022819519043},{"id":"https://openalex.org/C2778120352","wikidata":"https://www.wikidata.org/wiki/Q3870163","display_name":"Nanoparticle tracking analysis","level":5,"score":0.4726373553276062},{"id":"https://openalex.org/C189942447","wikidata":"https://www.wikidata.org/wiki/Q61186","display_name":"Microsphere","level":2,"score":0.4545414447784424},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.41926640272140503},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40007323026657104},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3148624300956726},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3113567531108856},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.24731236696243286},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.08190128207206726},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07499676942825317},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.0745382308959961},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C20518536","wikidata":"https://www.wikidata.org/wiki/Q6840469","display_name":"Microvesicles","level":4,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005780","descriptor_name":"Gelatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005780","descriptor_name":"Gelatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013499","descriptor_name":"Surface Properties","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061605","descriptor_name":"Administration, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.2147/dddt.s173485","doi":"https://doi.org/10.2147/dddt.s173485","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s173485","pdf_url":null,"source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6151103","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6151103/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6151103/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Des Devel Ther","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:5105101","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6151103","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:30271120","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30271120","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug design, development and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:7f986401b6c94c7f8cc45b2b7e790139","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7f986401b6c94c7f8cc45b2b7e790139","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Design, Development and Therapy, Vol Volume 12, Pp 3051-3060 (2018)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/40707","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/chemotherapeutic-drug-targeting-to-lungs-by-way-of-microspheres-after--peer-reviewed-article-DDDT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/dddt.s173485","doi":"https://doi.org/10.2147/dddt.s173485","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dddt.s173485","pdf_url":null,"source":{"id":"https://openalex.org/S2496126384","display_name":"Drug Design Development and Therapy","issn_l":"1177-8881","issn":["1177-8881"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Design, Development and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324458","display_name":"Northern Borders University","ror":"https://ror.org/03j9tzj20"},{"id":"https://openalex.org/F4320328654","display_name":"Northern Border University","ror":null},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2891987403.pdf","grobid_xml":"https://content.openalex.org/works/W2891987403.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1988909654","https://openalex.org/W1996697333","https://openalex.org/W1996725509","https://openalex.org/W2000477211","https://openalex.org/W2006161061","https://openalex.org/W2014682822","https://openalex.org/W2026079995","https://openalex.org/W2040033900","https://openalex.org/W2050772463","https://openalex.org/W2051946179","https://openalex.org/W2063445996","https://openalex.org/W2065263862","https://openalex.org/W2084487384","https://openalex.org/W2089869880","https://openalex.org/W2090826105","https://openalex.org/W2123291552","https://openalex.org/W2129689764","https://openalex.org/W2131487381","https://openalex.org/W2138331440","https://openalex.org/W2148287035","https://openalex.org/W2212044150","https://openalex.org/W2235523093","https://openalex.org/W2285693491","https://openalex.org/W2316842585","https://openalex.org/W2333605197","https://openalex.org/W2611606389"],"related_works":["https://openalex.org/W2011657095","https://openalex.org/W2414617312","https://openalex.org/W2357112052","https://openalex.org/W2064186309","https://openalex.org/W2292141861","https://openalex.org/W2005120206","https://openalex.org/W2059621816","https://openalex.org/W2018293508","https://openalex.org/W2314011505","https://openalex.org/W2364303109"],"abstract_inverted_index":{"Purpose:":[0],"Currently,":[1],"microsphere":[2],"technology":[3],"plays":[4],"a":[5,22,75,120,124,161,197,215],"major":[6],"role":[7],"in":[8,59,98,141,145,179,188,219,221],"the":[9,17,28,34,50,66,82,95,99,139,146,170,176,180,186,193,230,296],"development":[10],"of":[11,31,33,54,127,138,175,185,199,226,235,259,279,291],"many":[12],"new":[13],"cancer":[14],"therapies.":[15],"In":[16,130,167,228,294],"current":[18],"study,":[19],"we":[20],"proposed":[21],"targeted":[23],"drug-delivery":[24],"system":[25],"to":[26,40,155,164,169,207,223,314,327],"improve":[27],"treatment":[29],"efficacy":[30],"one":[32],"common":[35],"conventional":[36],"chemotherapeutic":[37,321],"drugs":[38,322],"used":[39,206],"treat":[41],"lung":[42,281],"tumors,":[43],"5-fluorouracil":[44,69],"(5-FU).":[45],"Materials":[46],"and":[47,52,63,94,245,269,306],"methods:":[48],"Following":[49],"preparation":[51],"optimization":[53],"small,":[55],"solid":[56],"microspheres,":[57,337],"ranging":[58],"diameter":[60,126],"between":[61],"5":[62],"15":[64],"\u00b5m,":[65],"final":[67],"product":[68],"gelatin":[70],"(5-FUG)":[71],"was":[72,88,101,110,143,190,205,254,313],"formulated":[73],"using":[74],"Buchi":[76],"Nano":[77],"Spray":[78],"Dryer":[79],"by":[80],"varying":[81],"drug:polymer":[83],"ratio.":[84],"Results:":[85],"Particle":[86,107],"yield":[87],"calculated":[89],"as":[90,103,112],"65%":[91],"\u00b1":[92,105],"1.2%,":[93],"drug":[96,132,173,177,187],"content":[97],"formulation":[100,298],"recorded":[102],"74%":[104],"1.6%.":[106],"surface":[108],"morphology":[109],"examined":[111],"shriveled":[113],"shape":[114],"(crumpled/folded);":[115],"particle":[116],"size":[117],"distribution":[118,218],"displayed":[119],"binomial":[121],"distribution,":[122],"with":[123],"mean":[125],"9.6":[128],"\u00b5m.":[129],"vitro":[131],"release":[133],"studies":[134],"revealed":[135],"that":[136,258,323],"~36.4%":[137],"5-FU":[140,172],"5-FUG":[142,189,212],"released":[144,178,191],"first":[147,181],"hour":[148],"after":[149,232],"injection.":[150],"Clinically,":[151],"this":[152],"would":[153],"lead":[154],"initial":[156],"or":[157,289],"burst":[158],"release,":[159],"facilitating":[160],"quick":[162],"rise":[163],"therapeutic":[165],"levels.":[166],"contrast":[168,222],"pure":[171],"(89.2%":[174],"30":[182],"minutes),":[183],"99.1%":[184],"from":[192],"spray-dried":[194],"particles":[195],"for":[196,319],"period":[198],"12":[200],"hours.":[201,277],"A":[202],"two-compartment":[203],"model":[204],"generate":[208],"plasma":[209],"concentration\u2013time":[210],"curves.":[211],"injection":[213,225,234],"has":[214],"much":[216],"different":[217,328],"vivo":[220],"intravenous":[224,233],"5-FU.":[227],"addition,":[229,295],"half-life":[231],"5-FUG,":[236],"t":[237,246,261,270],"1/2":[238,247,262,271],"(":[239,248,263,272],"\u03b1":[240,264],")":[241,250,265,274],"=":[242,251,266,275],"1.23":[243],"hours":[244,268],"\u03b2":[249,273],"18.3":[252],"hours,":[253],"considerably":[255],"longer":[256],"than":[257],"5-FU,":[260],"0.34":[267],"8.62":[276],"Examination":[278],"stained":[280],"tissue":[282,287],"sections":[283],"showed":[284],"no":[285],"histopathological":[286],"changes":[288],"evidence":[290],"gross":[292],"pathology.":[293],"optimized":[297],"demonstrated":[299],"an":[300],"increased":[301],"stability":[302],"under":[303],"both":[304],"long-term":[305],"refrigerated":[307],"storage":[308],"conditions.":[309],"Conclusion:":[310],"Our":[311],"goal":[312],"develop":[315],"similar":[316],"delivery":[317],"systems":[318],"other":[320],"are":[324],"site":[325],"specific":[326],"disease":[329],"models/tumor":[330],"types.":[331],"Keywords:":[332],"spray":[333],"drying,":[334],"5-fluorouracil,":[335],"cancer,":[336],"targeting":[338]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2018-09-27T00:00:00"}